The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions

Inclusion Criteria: * Patient must be at least \>18, ≤80 years of age. * Patient has Stable/unstable angina or NSTEMI. * Patient has STEMI\>24-hour from the onset of chest pain to admission. * Non-left-main coronary bifurcation lesion. (Medina 0,1,1;1,1,1;1,0,1;1,1,0). * Patient is eligible for elective percutaneous coronary intervention (PCI) . * Patient is an acceptable candidate for coronary artery bypass grafting (CABG). * Patient (or legal guardian) understands the trial requirements and treatment procedures and provides written informed consent before any trial-specific tests or procedures are performed; patient is willing to comply with all protocol-required follow-up evaluations. Exclusion Criteria: * Patient with STEMI (within 24-hour from the onset of chest pain to admission). * Patient has known allergy to the study stent system or protocol-required concomitant medications that cannot be adequately pre-medicated (everolimus, aspirin, contrast media, acrylic acid, Stainless steel). * Patient has intolerable to dual anti-platelet therapy. * Patient has any other serious medical illness that may reduce life expectancy to less than 12 months. * Patient is pregnant or nursing. * Patient is participating in another clinical trial that has not reached its primary endpoint. * Patient with severe calcified lesions needing rotational atherectomy. * Lesions of in-stent restenosis. * Patients not eligible for this trial based on investigators' judgement.